France: Ready for Ebola

With strong links with the West Coast of Africa, France is among countries most likely to experience Ebola, with an estimated 20% chance of cases in the homeland before October ends - a few suspected cases have arisen.

Photo: France: Ready for Ebola
Source: WHO /Stéphane Saporito

On daily flights to France from Conakry, Guinea, questionnaires record passengers’ destinations for later contact if necessary. Disembarked, they also undergo checks by Red Cross and Civil Protection Unit medics.

President François Hollande has announced that France would help the Guineans to build more anti-Ebola treatment centres (one is already constructed in Macenta), and French Civil Protection personnel will be deployed for training purposes.

The Bégin military hospital has 60 staff highly trained in infectious diseases and intensive care and has successfully used an experimental treatment for a Médecins Sans Frontières nurse who caught Ebola in Liberia.

Two other Paris hospitals and 12 French reference hospitals are also ready to handle cases.

In a patient’s negative pressure room, all initial laboratory tests are performed at the bedside in a specialised mini-laboratory. Results from samples sent to Lyon for analysis at the central high security reference laboratory, come within six hours

30.10.2014

Related articles

Photo

News • Fluorescence assay

A 'FAIRY' to rapidly determine virus infectivity

Researchers have developed a fluorescence assay for viral integrity (or FAIRY, for short), to quickly determine the effectiveness of countermeasures against a given virus.

Photo

Sponsored • Disease management

Multiplex Testing: A Solution to Manage Surge in Respiratory Illnesses as Concerns over “Multi-demic” Rise

Eunsin Bae, M.D. specializes in laboratory medicine and leads the Institute of Clinical Research at Seegene Inc. Her research focuses on microbiology, molecular biology, and hematology. Dr. Bae is…

Photo

News • Coronavirus mechanism discovered

Organ-on-a-chip reveals how SARS-CoV-2 invades blood vessels

A research group has revealed that SARS-CoV-2 disrupts the vascular endothelial barrier by suppressing the expression of Claudin-5 (CLDN5) to invade the blood vessels.

Related products

Subscribe to Newsletter